Full-Time

Assistant Manager

Sponsorship

Posted on 6/11/2025

Deadline 7/31/25
AstraZeneca

AstraZeneca

10,001+ employees

Develops and commercializes prescription medicines

No salary listed

Mid

Mumbai, Maharashtra, India

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary
Required Skills
Sales
Marketing
Requirements
  • University Science graduate., Bachelors degree
  • 3+ years of sales/marketing experience required
  • Comprehensive understanding of the Pharmaceutical Industry
  • Effective Influencing and Communication Skills
  • Proficiency in Customer Management
  • Strong Commercial Acumen
  • Organizational skills, good analytical skills / mind stability to manage complexity with a high degree of maturity
Responsibilities
  • Create and track the conference calendar for Oncology Business Unit
  • Work with Medical Team, Marketing team and Zonal Business Manager to understand the scientific needs in the region
  • Engage with HCPs to understand the platforms for scientific dissemination and to align with scientific needs/capability of AZ
  • Ability to negotiate with stakeholders to provide an adequate and appropriate representation for AZ on major scientific platforms
  • Ensure compliance with the AZ Code of Ethics, Global External Interactions Policy and Standards, and Privacy Policy and Standards, especially when interacting with HCPs/Third Party
  • Coordinate and execute end-to-end function for conference partnership with HCO
Desired Qualifications
  • Experience in super-speciality / Oncology preferred

AstraZeneca focuses on discovering, developing, and selling prescription medicines. The company specializes in three main areas: Oncology, which deals with cancer treatments; Cardiovascular, Renal & Metabolism, which addresses heart, kidney, and metabolic diseases; and Respiratory & Immunology, which targets lung and immune system diseases. Their products are developed through extensive research and development, followed by clinical trials and regulatory approvals before reaching the market. AstraZeneca differentiates itself from competitors by investing heavily in scientific research and forming strategic partnerships to enhance drug discovery. Their goal is to advance healthcare by providing effective treatments for serious diseases while collaborating with the scientific community to improve their research capabilities.

Company Size

10,001+

Company Stage

IPO

Headquarters

Cambridge, United Kingdom

Founded

1913

Simplify Jobs

Simplify's Take

What believers are saying

  • AI-driven drug discovery platforms complement AstraZeneca's R&D efforts.
  • The rise of personalized medicine aligns with AstraZeneca's precision diagnostics partnership with Danaher.
  • Telemedicine expansion provides new channels for AstraZeneca to reach patients and providers.

What critics are saying

  • Geopolitical tensions may affect AstraZeneca's collaboration with CSPC in China.
  • Calquence faces competition in the EU, impacting market share and profitability.
  • The Rockville cell therapy facility's investment may not be recouped if market growth stalls.

What makes AstraZeneca unique

  • AstraZeneca focuses on three main therapy areas: Oncology, Cardiovascular, and Respiratory.
  • The company invests heavily in R&D to create innovative prescription medicines.
  • AstraZeneca's A.Catalyst Network fosters global collaboration and innovation in healthcare.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

Paid Vacation

Paid Holidays

Flexible Work Hours

Company News

Cision
Jun 13th, 2025
Astrazeneca Enters Into Collaboration With Cspc

AstraZeneca enters into collaboration with CSPC

Cision
Jun 6th, 2025
Fixed-Duration Calquence Approved In Eu For 1L Cll

Fixed-duration Calquence approved in EU for 1L CLL

Business Weekly
Jun 5th, 2025
Sortera Bio secures £7.5m pre-seed funding

Sortera Bio, a Cambridge biotech, secured a £7.5m pre-seed round led by Cambridge Innovation Capital, with AstraZeneca and BioNTech participating. The funding will enhance Sortera's Deep Screening platform, which uses AI for drug discovery. Co-founded by Dr. Ben Porebski and Dr. Philipp Holliger, Sortera aims to deliver precision biologics. The technology was developed at the MRC Laboratory of Molecular Biology with AstraZeneca's support.

Pharmashots
Jun 2nd, 2025
AstraZeneca Presents P-III (MATTERHORN) Trial Data of Imfinzi as Perioperative Therapy for G/GEJ Cancers at ASCO 2025

AstraZeneca has shared P-III (MATTERHORN) trial data assessing perioperative Imfinzi + FLOT (n=474) vs PBO + FLOT (n=474) in 948 pts with stage II-IVA G/GEJ cancers at ASCO 2025

Cision
Jun 2nd, 2025
Block Listing Interim Review

2 June 2025 BLOCK LISTING SIX MONTHLY RETURN Information provided on this form must be typed or printed electronically and provided to an ris. (Note: Italicised terms have the same meaning as given in the Listing Rules.) Date: 2 June 2025 Name of applicant: ASTRAZENECA PLC Name of scheme: ASTRAZENECA SHARE OPTION PLAN; ASTRAZENECA SAVINGS -RELATED SHARE OPTION PLAN;